United States Securities and Exchange Commission · EDGAR Accession 0002088182-25-000002

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-36411
Issuer CIK 2088182
Raising via MICROVENTURE MARKETPLACE INC.

EmerRx Biopharma, LLC

Limited Liability CompanyDEIncorporated 2025ALAMEDA, CAemerrx.com
Nature of amendmentAMENDMENT TO EXTEND OFFERING DEADLINE AND ALLOW FOR THE COMPANY TO ELECT TO CONDUCT INTERMEDIATE CLOSES.
A

The Offering

as disclosed in this filing
Other (CROWD NOTES)
$1.00
$25,000
$250,000
December 29, 2025
Expired 167 days ago
$0max $250,000

Target is 10% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Debt / assets 57%4 employees
Line itemMost recent FYPrior FYΔ
Revenue5000
Cost of goods sold00
Net income(209,440)0
Total assets80,3210
Cash & equivalents79,6210
Accounts receivable7000
Short-term debt46,0100
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36411 · all filings under this campaign
Loading campaign history…